Psoriasis Completed Phase 2 Trials for MM-093 (DB05512)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00147329Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque PsoriasisTreatment